Savara
SVRA
#6023
Rank
A$1.48 B
Marketcap
A$7.22
Share price
0.10%
Change (1 day)
97.25%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -A$0.19 Billion

According to Savara's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 -A$0.17 Billion23.94%
2024 -A$0.14 Billion75.29%
2023 -A$77.54 Million43.38%
2022 -A$54.08 Million-11.31%
2021 -A$60.98 Million-13.3%
2020 -A$70.33 Million-36.53%
2019 -A$0.12 Billion13.76%
2018 -A$97.41 Million105.54%
2017 -A$47.4 Million34.11%
2016 -A$35.34 Million-37.43%
2015 -A$56.48 Million38.81%
2014 -A$40.69 Million33.62%
2013 -A$30.45 Million38.49%
2012 -A$21.99 Million24.59%
2011 -A$17.65 Million-36.5%
2010 -A$27.79 Million-3.14%
2009 -A$28.7 Million-23.28%
2008 -A$37.4 Million8.52%
2007 -A$34.47 Million-34.14%
2006 -A$52.33 Million184.43%
2005 -A$18.4 Million90.75%
2004 -A$9.65 Million190.35%
2003 -A$3.33 Million11.64%
2002 -A$2.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.23 Billion 34.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$25.74 Million-84.72%๐Ÿ‡บ๐Ÿ‡ธ USA